| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.27 | 3e-05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.48 | 0.0006 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |